Influenza remains a significant public health challenge, and antiviral medications have been developed as essential tools for managing the disease. A recent systematic review and meta-analysis scrutinizes the effectiveness of these antiviral agents and presents intriguing findings, particularly regarding baloxavir (Xofluza) and oseltamivir (Tamiflu). The implications of this research raise important considerations about the treatment
0 Comments